TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
South Korea · Delayed Price · Currency is KRW 2,245.00
-180.00 (-7.42%)
Jul 1, 2026, 1:20 PM KST
TELCON RF PHARMACEUTICAL. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -8,298 | -11,456 | -26,320 | 13,906 | -42,084 | -23,098 |
Depreciation & Amortization | 4,893 | 4,824 | 4,507 | 4,244 | 4,281 | 4,200 |
Loss (Gain) From Sale of Assets | -521.92 | -486.92 | -17.27 | 14.8 | -34.38 | 250.45 |
Asset Writedown & Restructuring Costs | 1,324 | 1,324 | 1,097 | 64.8 | 4,411 | 3,005 |
Loss (Gain) From Sale of Investments | 7,299 | 5,817 | -1,275 | -13,466 | 13,146 | -4,626 |
Loss (Gain) on Equity Investments | 16.18 | 3,709 | 24,684 | -469.53 | 17,868 | 13,196 |
Stock-Based Compensation | 3.58 | - | - | - | - | - |
Provision & Write-off of Bad Debts | -216.67 | -417.28 | 206.34 | 251.8 | 746.56 | -19.19 |
Other Operating Activities | -396.99 | 1,041 | 618.75 | 963.05 | 2,648 | 7,383 |
Change in Accounts Receivable | -3,445 | -2,958 | -3,908 | -6,563 | -1,450 | -791.38 |
Change in Inventory | 151.32 | -1,119 | 528.74 | -717.74 | -1,684 | -677.17 |
Change in Accounts Payable | 1,061 | 1,145 | 1,572 | 503.37 | 646.52 | 60.21 |
Change in Other Net Operating Assets | -940.28 | 242.36 | -474.55 | 133.25 | -586.66 | 758.06 |
Operating Cash Flow | 929.32 | 1,667 | 1,219 | -1,135 | -2,093 | -358.56 |
Operating Cash Flow Growth | - | 36.73% | - | - | - | - |
Capital Expenditures | -524.63 | -319.81 | -4,968 | -3,820 | -819.43 | -2,254 |
Sale of Property, Plant & Equipment | 35 | - | 18.05 | 5.88 | 66.81 | 60.24 |
Cash Acquisitions | -30.98 | -30.98 | - | - | - | - |
Divestitures | 505.56 | 505.56 | - | - | - | - |
Sale (Purchase) of Intangibles | - | - | -7.13 | -18 | -14.52 | -3,559 |
Investment in Securities | -8,500 | 6,401 | -44,536 | 419.38 | -7,082 | 6,508 |
Other Investing Activities | 111.94 | 194.38 | 38.83 | -32.32 | 46.34 | 124.26 |
Investing Cash Flow | -22,518 | -1,345 | -44,084 | -10,525 | -7,885 | 879.02 |
Short-Term Debt Issued | - | 2,800 | 36,600 | - | 200 | - |
Long-Term Debt Issued | - | 11,880 | 29,780 | 13,108 | 1,000 | - |
Total Debt Issued | 17,680 | 14,680 | 66,380 | 13,108 | 1,200 | - |
Short-Term Debt Repaid | - | -19,400 | -18,000 | -200 | - | - |
Long-Term Debt Repaid | - | -12,715 | -10,737 | -2,947 | -4,640 | -1,922 |
Total Debt Repaid | -30,715 | -32,115 | -28,737 | -3,147 | -4,640 | -1,922 |
Net Debt Issued (Repaid) | -13,035 | -17,435 | 37,643 | 9,961 | -3,440 | -1,922 |
Issuance of Common Stock | 40,193 | 40,193 | - | - | - | - |
Other Financing Activities | -252.59 | -252.59 | 8.55 | 484.74 | - | 31.01 |
Financing Cash Flow | 26,905 | 22,505 | 37,651 | 10,445 | -3,440 | -1,891 |
Foreign Exchange Rate Adjustments | 3 | -7.65 | 0.6 | -0.46 | -43.32 | 24.42 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | - |
Net Cash Flow | 5,319 | 22,819 | -5,213 | -1,214 | -13,462 | -1,346 |
Free Cash Flow | 404.69 | 1,347 | -3,749 | -4,954 | -2,912 | -2,613 |
Free Cash Flow Margin | 0.94% | 3.12% | -9.90% | -13.64% | -10.46% | -6.90% |
Free Cash Flow Per Share | 72.15 | 280.76 | -1056.80 | -1104.29 | -706.88 | -991.33 |
Cash Interest Paid | 1,747 | 2,065 | 1,304 | 553.73 | 861.4 | 2,419 |
Cash Income Tax Paid | - | -213.9 | 200.01 | 45.14 | -27.4 | 40.1 |
Levered Free Cash Flow | -16,521 | -8,886 | 10,349 | -5,322 | 316 | -7,715 |
Unlevered Free Cash Flow | -13,743 | -5,878 | 12,699 | -4,945 | 980.21 | -2,901 |
Change in Working Capital | -3,173 | -2,689 | -2,282 | -6,644 | -3,074 | -650.28 |